Cohance Lifescience receives USFDA Form 483 with four observations at Telangana plant

thehawk.in 3 h

India

Cohance Lifescience receives USFDA Form 483 with four observations at Telangana plant — Sources: thehawk.in

Cohance Lifescience receives USFDA Form 483 with four observations for its formulation facility. The company is committed to addressing the observations and maintaining regulatory compliance.

See all — thehawk.in →

Aggregated from the leading newsrooms of the country. Every story links to its original source.

Cohance Lifescience receives USFDA Form 483 with four observations at Telangana plant

Top stories

Subscribe To Print Edition

Mutual Funds

Personal Finance

11 IPOs worth Rs 7,055 crore to hit D-Street next week; Rentomojo, Karamtara among key issues

Iran planning ‘multi-front’ attack on Israel with Hezbollah, Hamas, Houthis, Iraqi militias

Air India Phuket-Delhi flight lost all 3 hydraulic systems at 36,000 feet, seatbelt signs were off

India fills Europe’s diesel gap as Russian exports slump, US shipments decline

Positive Start Expected for Nifty | SEBI to review derivative settlement pricing process